Hong Kong Stock Movement | Keymed Biosciences-B (02162.HK) rose over 8% intraday; the company has strong competitive advantages in multiple innovative drug fields such as autoimmune diseases and oncology.
Zhito Finance APP has learned that Keymed Biosciences-B (02162.HK) rose over 8%, up 6.26% as of press time, at HK$77.8, with a turnover of HK$144 million.
Latest
